The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Angiotensin II–Induced Hypertension Accelerates the Development of Atherosclerosis in ApoE-Deficient Mice
Open accessAbstract
Background —Angiotensin II may contribute to the development and progression of atherosclerotic lesions because of its growth and proinflammatory effects. We sought to determine whether angiotensin II–induced hypertension would augment and accelerate the development of atherosclerotic lesions in apoE-deficient mice. Methods and Results —Angiotensin II (0.7 mg · kg −1 · d −1 SC) was administered to apoE-deficient mice via osmotic minipumps. The animals were placed on either standard chow or an atherogenic diet. After 8 weeks, the mean atherosclerotic lesion area in the descending thoracic and abdominal aortas of animals on a standard chow diet was 0.4±0.1% compared with 5.2±1.2% in those animals maintained on an atherogenic diet ( P <0.0001). In angiotensin II–treated animals on standard chow, the mean lesion area was increased to 11.0±2.3%, which was further increased to 69.9±9.4% ( P <0.0001) in angiotensin II–treated animals on an atherogenic diet. Similar findings were obtained when tissues from the ascending aorta were analyzed. At 8 weeks in mice receiving a standard chow diet, angiotensin II dramatically increased the atherosclerotic lesion area by 840±83 μm 2 ( P <0.0001). Animals on a high-fat diet had a similar marked increase in lesion area in response to angiotensin II (217±19 μm 2 , P <0.0001). In contrast, when hypertension was induced with norepinephrine, only a modest effect on the atherosclerotic lesion area was observed. Conclusions —Angiotensin II–induced hypertension specifically increased the development of atherosclerosis in apoE knockout mice. This response was seen in animals receiving either standard chow or an atherogenic diet. These studies demonstrate the profound effect of angiotensin II on the development of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice
Daugherty, A., Manning, M. W., & Cassis, L. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7818 · Cited by 1,368
Marui, N., Offermann, M. K., Swerlick, R., Kunsch, C., Rosen, C. A., Ahmad, M., Alexander, R. W., & Medford, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116778 · Cited by 1,072
Alexander, R. W. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.155 · Cited by 785
Alderman, M. H., Madhavan, S., Ooi, W. L., Cohen, H., Sealey, J. E., & Laragh, J. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241605 · Cited by 730
Variation in susceptibility to atherosclerosis among inbred strains of mice
PAIGEN, B., MORROW, A., BRANDON, C., MITCHELL, D., & HOLMES, P. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90138-8 · Cited by 612
Role of NADH/NADPH Oxidase–Derived H2O2in Angiotensin II–Induced Vascular Hypertrophy
Zafari, A. M., Ushio-Fukai, M., Akers, M., Yin, Q., Shah, A., Harrison, D. G., Taylor, W. R., & Griendling, K. K. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.488 · Cited by 612
Self-citationA Noninvasive Computerized Tail-Cuff System for Measuring Blood Pressure in Mice
Krege, J. H., Hodgin, J. B., Hagaman, J. R., & Smithies, O. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.1111 · Cited by 587
Tangirala, R. K., Rubin, E. M., & Palinski, W. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39713-3 · Cited by 514
Palinski, W., Ord, V. A., Plump, A. S., Breslow, J. L., Steinberg, D., & Witztum, J. L. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.605 · Cited by 488
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells
Kranzhöfer, R., Schmidt, J., Pfeiffer, C. A. H., Hagl, S., Libby, P., & Kübler, W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.7.1623 · Cited by 480
Established Risk Factors and Coronary Artery Disease: The Framingham Study
Wilson, P. W. F. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.7.7s · Cited by 438
Angiotensin II Signaling in Vascular Smooth Muscle: New Concepts
Griendling, K. K., Ushio-Fukai, M., Lassègue, B., & Alexander, R. W. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.366 · Cited by 407
Chen, X.-L., Tummala, P. E., Olbrych, M. T., Alexander, R. W., & Medford, R. M. (1998) · Circulation Research · doi:10.1161/01.res.83.9.952 · Cited by 385
Oxidative Stress and Cardiovascular Disease
(2019) · Cardiovascular Disease · doi:10.1002/9781118829875.ch9 · Cited by 330
Swales, J. D. (1994) · Blackwell Scientific Publications eBooks · Cited by 305
Wung, B. S., Cheng, J. J., Hsieh, H. J., Shyy, Y. J., & Wang, D. L. (1997) · Circulation Research · doi:10.1161/01.res.81.1.1 · Cited by 237
Monocyte Chemoattractant Protein-1 Expression in Aortic Tissues of Hypertensive Rats
Capers, Q., Alexander, R. W., Lou, P., Leon, H. D., Wilcox, J. N., Ishizaka, N., Howard, A. B., & Taylor, W. R. (1997) · Hypertension · doi:10.1161/01.hyp.30.6.1397 · Cited by 222
Self-citationHishikawa, K., Oemar, B. S., Yang, Z., & Lüscher, T. F. (1997) · Circulation Research · doi:10.1161/01.res.81.5.797 · Cited by 202
Plasma Renin Activity: A Risk Factor for Myocardial Infarction in Hypertensive Patients
Alderman, M. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(96)00301-9 · Cited by 192
Cyclic strain induces an oxidative stress in endothelial cells
Howard, A. B., Alexander, R. W., Nerem, R. M., Griendling, K. K., & Taylor, W. R. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.2.c421 · Cited by 174
Self-citationOut-of-hospital cardiac arrests in Helsinki: Utstein style reporting.
Kuisma, M., & Määttä, T. (1996) · Heart · doi:10.1136/hrt.76.1.18 · Cited by 165
Wu, Y., Hong, C., Lin, S., Wu, P., & Shiao, M. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.3.481 · Cited by 159
Keidar, S., Attias, J., Smith, J. D., Breslow, J. L., & Hayek, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6844 · Cited by 141
Schuh, J. R., Blehm, D. J., Frierdich, G. E., McMahon, E. G., & Blaine, E. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116350 · Cited by 109
The Epidemiology of Plasma Renin
Meade, T. W., Imeson, J., Gordon, D., & Peart, W. S. (1983) · Clinical Science · doi:10.1042/cs0640273 · Cited by 103
Plasma Renin Activity and Ischemic Heart Disease
Meade, T. W., Cooper, J. A., & Peart, W. S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308263290905 · Cited by 102
Kowala, M. C., Grove, R. I., & Åberg, G. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90037-x · Cited by 98
Schwenke, D. C., & Behr, S. R. (1998) · Circulation Research · doi:10.1161/01.res.83.4.366 · Cited by 98
Ethnic differences in circadian hemodynamic profile.
Gretler, D. D., Fumo, M., Nelson, K., & Murphy, M. B. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.1.7 · Cited by 95
Antioxidant Effects of Lovastatin and Vitamin E on Experimental Atherosclerosis in Rabbits
Singh, R. B., Singh, N. K., Rastogi, S. S., Wander, G. S., Aslam, M., Onouchi, Z., Kummerow, F. A., & Nangia, S. (1997) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007787721410 · Cited by 36
Mechanical Deformation of the Arterial Wall in Hypertension: A Mechanism for Vascular Pathology
Taylor, W. R. (1998) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40395-7 · Cited by 22
Self-citation
Cited by
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Atherosclerotic Lesion Size and Vulnerability Are Determined by Patterns of Fluid Shear Stress
Cheng, C., Tempel, D., van Haperen, R., van der Baan, A., Grosveld, F., Daemen, M. J. A. P., Krams, R., & de Crom, R. (2006) · Circulation · doi:10.1161/circulationaha.105.590018 · Cited by 1,000
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis
Intengan, H. D., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/hy09t1.096249 · Cited by 979
Oxidative Stress and Cardiovascular Injury: Part I: Basic Mechanisms and In Vivo Monitoring of ROS
Griendling, K. K., & FitzGerald, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000093660.86242.bb · Cited by 941
Oxidative Stress and Cardiovascular Injury: Part II: Animal and Human Studies
Griendling, K. K., & FitzGerald, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000093661.90582.c4 · Cited by 721
Metadata
- Authors
- Weiss, D., Kools, J. J., & Taylor, W. R.
- Venue
- Circulation
- Published
- 2001-01-23
- Volume
- 103
- Issue
- 3
- Pages
- 448-454
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2012663953
- Cited by
- 368
- References
- 36
- FWCI
- 13.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.